Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Not yet open
Novo Nordisk A/S
Phase 3
8,500
Marbella, A Coruña, Barcelona, Boadilla del Monte, Cáceres, Córdoba, El Palmar, Granada
2026-10-26
Not yet open
University of Mons
Not applicable
200
Barcelona, Cadiz, Cáceres, Valencia, Valladolid
2026-07
Recruiting
Taiho Oncology, Inc.
Phase 1
140
Barcelona, Cáceres, Madrid, Seville
2026-06-22
Recruiting
PETHEMA Foundation
Phase 2
50
Albacete, Alicante, Burgos, Cáceres, Córdoba, Las Palmas, Las Palmas de Gran Canaria, Lugo
2026-06-12
Recruiting
Regeneron Pharmaceuticals
Phase 3
35
Bilbao, Barcelona, Cáceres, Murcia, Salamanca
2026-06-11
Recruiting
Quetzal Therapeutics
Phase 3
150
Palma de Mallorca, Badalona, Barcelona, Cáceres, Málaga, Oviedo, Valencia
2026-06-08
Recruiting
Janssen Research & Development, LLC
Phase 3
700
Barcelona, Cáceres, Córdoba, Jerez de la Frontera, Madrid, Pamplona, Salamanca, Santander
2026-05-31
Recruiting
Novartis Pharmaceuticals
Phase 3
5,700
Santiago Compostela, Seville, Badalona, L'Hospitalet de Llobregat, Santander, Cáceres, Reus, A Coruña
2026-05-11
Recruiting
Eli Lilly and Company
Phase 3
800
Badajoz, Barcelona, Cáceres, Donostia / San Sebastian, Granada, Hospitalet, Jaén, Las Palmas de Gran Canaria
2025-12-22
Active, closed
University of Extremadura
Not applicable
50
Cáceres
2025-11-07
Recruiting
Stemline Therapeutics, Inc.
Observational
140
Albacete, Alicante, Badalona, Burgos, Cáceres, Córdoba, Madrid, Oviedo
2025-10-17
Active, closed
University of Extremadura
Not applicable
434
Cáceres
2025-09-29
Recruiting
Sanofi
Phase 3
942
Mérida, L'Hospitalet de Llobregat, Jerez de la Frontera, Benalmádena, Cáceres, Málaga, Palma, Seville
2025-09-16
Recruiting
Relay Therapeutics, Inc.
Phase 3
540
Badajoz, Badalona, Barcelona, Castellon, Cáceres, El Palmar, Girona, Huelva
2025-08-26
Recruiting
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Phase 2
80
Seville, Zaragoza, Palma de Mallorca, Burgos, Salamanca, Badalona, Barcelona, Cáceres
2025-08-04
Recruiting
Celcuity Inc
Phase 3
1,180
A Coruña, Badajoz, Barcelona, Cáceres, El Palmar, L'Hospitalet de Llobregat, Lleida, Madrid
2025-07-24
Active, closed
Upstream Bio Inc.
Phase 2
666
Palma de Mallorca, Torrelavega, Jerez de la Frontera, Cáceres, Granada, Madrid, Pozuelo de Alarcón, Benalmádena
2025-07-02
Recruiting
MedSIR
Phase 2
200
Barcelona, Cáceres, Girona, Granada, Jaén, Madrid, Majadahonda, Murcia
2025-06-30
Recruiting
Janssen Research & Development, LLC
Phase 3
600
A Coruña, Barcelona, Cáceres, Jerez de la Frontera, L'Hospitalet de Llobregat, Madrid, Pamplona, Pozuelo de Alarcón
2025-06-04
Recruiting
AstraZeneca
Phase 3
15,100
A Coruña, Alicante, Barcelona, Cáceres, Huelva, Madrid, Málaga, Murcia
2025-06-04
Recruiting
Grupo Español Multidisciplinar de Melanoma
Phase 2
33
A Coruña, Barcelona, Burgos, Santander, Cáceres, Donostia / San Sebastian, Madrid, Majadahonda
2025-05-29
Recruiting
Eikon Therapeutics
Phase 2/3
740
Santiago de Compostela, Badalona, Barcelona, Santander, Cáceres, Lugo, Girona, Madrid
2025-05-22
Recruiting
Biogen
Phase 3
454
Viladecans, Barcelona, A Coruña, Alcorcón, Getafe, Cáceres, Girona, Madrid
2025-05-08
Active, closed
Universidad de Extremadura
Not applicable
728
Cáceres
2025-04-28
Recruiting
Stelexis BioSciences
Phase 1
125
Cáceres, Valencia
2025-04-28
Recruiting
AstraZeneca
Phase 3
400
Alcorcón, Alzira (Valencia), Badalona, Barakaldo, Barcelona, Burgos, Cáceres, Granada
2025-03-28
Active, closed
University of Extremadura
Not applicable
60
Cáceres
2025-02-17
Recruiting
MedSIR
Phase 3
300
Barcelona, A Coruña, Alicante, Badalona, Bilbao, Burgos, Castellon, Cáceres
2024-12-05
Recruiting
Puma Biotechnology, Inc.
Phase 2
225
Alicante, Barakaldo, Barcelona, Bilbao, Cáceres, Granada, Huelva, Jaén
2024-11-19
Active, closed
Daiichi Sankyo
Phase 3
700
Albacete, Alicante, Badalona, Barcelona, Burgos, Cáceres, Córdoba, Las Palmas
2024-11-19
Recruiting
Stemline Therapeutics, Inc.
Phase 3
4,220
Vigo, Seville, Badalona, Sant Cugat del Vallès, Sant Joan Despí, San Cristóbal de La Laguna, Cáceres, Móstoles
2024-09-27
Recruiting
AstraZeneca
Phase 3
788
A Coruña, Barcelona, Cáceres, Granada, L'Hospitalet de Llobregat, Madrid, Málaga, Pamplona
2024-08-01
Active, closed
AbbVie
Phase 2
108
Barcelona, Cáceres, Jaén, Madrid, Valencia
2024-07-29
Active, closed
Byondis B.V.
Phase 1
16
Badalona, Barcelona, Cáceres, Salamanca, Valencia
2024-06-25
Recruiting
X4 Pharmaceuticals
Phase 3
176
Barcelona, Cáceres, Córdoba, Las Palmas de Gran Canaria, Madrid, Santander, Seville, Valencia
2024-06-06
Recruiting
Kartos Therapeutics, Inc.
Phase 3
600
Badalona, Barcelona, Cáceres, Las Palmas de Gran Canaria, Madrid, Málaga, Salamanca, Valencia
2024-06-03
Active, closed
Syndax Pharmaceuticals
Phase 1
96
Santander, Barcelona, Cáceres, Granada, Madrid, Salamanca, Seville, Valencia
2024-05-21
Recruiting
Hospital Clinico Universitario de Santiago
Not applicable
1,036
Santiago de Compostela, A Coruña, Albacete, Barcelona, Cáceres, Denia, Elche, Gijón
2024-05-01
Recruiting
Karyopharm Therapeutics Inc
Phase 2
58
Badalona, El Palmar, Oviedo, Cáceres, Girona, Las Palmas de Gran Canaria, Salamanca, Valencia
2024-04-22
Recruiting
Novartis Pharmaceuticals
Phase 2
502
Cáceres, Córdoba, Madrid, Salamanca, Valencia
2024-03-07
Active, closed
Genmab
Phase 3
1,095
Badalona, L'Hospitalet de Llobregat, Santander, Pamplona, Barcelona, Cáceres, Madrid, Salamanca
2024-02-05
Active, closed
Janssen Research & Development, LLC
Phase 3
838
Asturias, Barcelona, Burgos, Cáceres, Donostia / San Sebastian, Granada, Lugo, Madrid
2024-01-22
Recruiting
Ryvu Therapeutics SA
Phase 2
98
Barcelona, Cáceres, Madrid, Málaga, Pamplona, Seville, Valencia
2024-01-05
Active, closed
Amgen
Phase 3
633
Seville, Badalona, Cáceres, El Palmar, Barcelona, Madrid, Málaga, Valencia
2023-11-02
Recruiting
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
2,295
Albacete, Alicante, Alzira, Barakaldo, Barcelona, Bilbao, Cadiz, Cáceres
2023-10-24
Active, closed
iVascular S.L.U.
Phase 3
2,312
A Coruña, Almería, Barcelona, Cáceres, Huelva, Jerez de la Frontera, Las Palmas de Gran Canaria, León
2023-10-13
Recruiting
Ascentage Pharma Group Inc.
Phase 3
350
Badalona, Barcelona, Cáceres, Madrid, Santander, Seville, Valencia
2023-08-31
Recruiting
Fundación EPIC
Observational
3,000
A Coruña, Badajoz, Badalona, Barakaldo, Barcelona, Cáceres, Ciudad Real, Huelva
2023-08-04
Recruiting
Artios Pharma Ltd
Phase 1/2
181
Granada, Valladolid, Barcelona, Cáceres, San Carlos, Cadiz, Madrid, Murcia
2023-06-30
Active, closed
Bristol-Myers Squibb
Phase 3
1,230
Barcelona, Cáceres, Las Palmas de Gran Canaria, Murcia, Oviedo, Valencia, Badalona, Madrid
2023-06-22
Recruiting
Hoffmann-La Roche
Phase 3
420
L'Hospitalet de Llobregat, Santiago de Compostela, San Cristóbal de La Laguna, Barcelona, Cáceres, Madrid, Málaga, Murcia
2023-06-07
Active, closed
Janssen Research & Development, LLC
Phase 2
68
Barcelona, Cáceres, Jerez de la Frontera, L'Hospitalet de Llobregat, Madrid, Málaga, Palma de Mallorca, Santiago de Compostela
2023-05-18
Active, closed
Fundación GECP
Phase 2
22
Alicante, Barcelona, Mataró, Bilbao, Cáceres, Jerez de la Frontera, Girona, Jaén
2023-05-12
Recruiting
Fundación EPIC
Observational
508
Elche, A Coruña, Barakaldo, Barcelona, Castelló, Cáceres, Ciudad Real, Girona
2023-05-10
Recruiting
Centro Nacional de Investigaciones Oncologicas CARLOS III
Observational
300
A Coruña, Fuenlabrada, Palma de Mallorca, Pamplona, Seville, Barcelona, Cáceres, Madrid
2023-03-02
Recruiting
SOLTI Breast Cancer Research Group
Phase 2
96
Badalona, L'Hospitalet de Llobregat, Vilanova, El Palmar, Badajoz, Barcelona, Cáceres, Madrid
2023-02-03
Recruiting
Greenwich LifeSciences, Inc.
Phase 3
2,250
Albacete, Alicante, Badajoz, Barcelona, Cáceres, Córdoba, El Palmar, Fuenlabrada
2022-12-16
Recruiting
Gilead Sciences
Phase 3
1,514
A Coruña, Badalona, Barakaldo, Barcelona, Castellon, Cáceres, Córdoba, Donostia / San Sebastian
2022-12-12
Active, closed
Celcuity Inc
Phase 3
701
Madrid, Badajoz, Barcelona, Cáceres, Murcia, Santiago de Compostela
2022-12-08
Recruiting
Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa
Not applicable
40
Badalona, L'Hospitalet de Llobregat, Manresa, Sabadell, Sant Joan Despí, Terrassa, Cáceres, Girona
2022-11-29
Recruiting
GBG Forschungs GmbH
Observational
400
Córdoba, Bilbao, Santa Cruz de Tenerife, Badalona, Barcelona, Lleida, Sabadell, Cáceres
2022-10-12
Active, closed
Eli Lilly and Company
Phase 3
8,000
A Coruña, Alicante, Almería, Badajoz, Barcelona, Bilbao, Burgos, Cáceres
2022-10-04
Active, closed
Genmab
Phase 3
549
Badalona, L'Hospitalet de Llobregat, Santander, Córdoba, Pamplona, Barcelona, Cáceres, Madrid
2022-09-20
Recruiting
Celgene
Phase 3
810
Palma, Barcelona, Murcia, Marbella, Cáceres, León, Madrid
2022-09-20
Active, closed
Celgene
Phase 3
939
Pamplona, Barcelona, Cáceres, Córdoba, Madrid, Málaga, Murcia, Oviedo
2022-06-23
Recruiting
AB Science
Phase 1/2
78
Alicante, Cáceres, Madrid, Pamplona, Seville
2022-06-01
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
654
Málaga, Palma de Mallorca, EI Palmar, Barcelona, Cáceres, Madrid, Valencia, La Laguna Tenerife
2022-03-07
Recruiting
Sumitomo Pharma America, Inc.
Phase 1/2
606
Albacete, Barcelona, Cáceres, Las Palmas, Madrid, Oviedo, Salamanca, Santander
2022-02-28
Recruiting
ARCAGY/ GINECO GROUP
Phase 2
390
A Coruña, Barcelona, Cáceres, El Palmar, Murcia, Jerez de la Frontera, Madrid, Málaga, Oviedo
2022-02-01
Active, closed
Gilead Sciences
Phase 3
603
A Coruña, Badalona, Barakaldo, Barcelona, Cáceres, Girona, Madrid, Málaga
2021-11-17
Active, closed
Fundación EPIC
Observational
400
Málaga, Barakaldo, Barcelona, Cáceres, Ciudad Real, Donostia / San Sebastian, Elche, Galdakao
2021-10-29
Active, closed
Eli Lilly and Company
Phase 3
874
Barcelona, Cáceres, Lleida, Madrid, San Cristóbal de La Laguna, Valencia, Granada, Seville
2021-10-04
Active, closed
GlaxoSmithKline
Phase 3
40
Barcelona, Cáceres, Córdoba, Granada, Madrid, Málaga, Santiago de Compostela, Valencia
2021-06-28
Active, closed
Geron Corporation
Phase 3
327
Alicante, Badalona, Las Palmas de Gran Canaria, Cáceres, Granada, Madrid, Málaga, Zaragoza
2021-04-12
Active, closed
Novartis Pharmaceuticals
Phase 3
430
Oviedo, Badalona, Barcelona, Cáceres, Las Palmas de Gran Canaria, Madrid, Murcia, Salamanca
2021-04-09
Active, closed
SOLTI Breast Cancer Research Group
Phase 2
55
Granada, Barcelona, L'Hospitalet de Llobregat, Santa Cruz de Tenerife, A Coruña, Alicante, Cáceres, León
2021-03-15
Active, closed
Karyopharm Therapeutics Inc
Phase 3
353
Cáceres, Oviedo, Zaragoza, Badalona, Barcelona, Girona, Las Palmas de Gran Canaria, Lugo
2021-03-11
Active, closed
Loxo Oncology, Inc.
Phase 3
238
L'Hospitalet de Llobregat, Toledo, Santiago de Compostela, Pozuelo de Alarcón, Madrid, Albacete, Barcelona, Cáceres
2021-03-09
Active, closed
Sellas Life Sciences Group
Phase 3
127
Cáceres, Córdoba, Madrid, Oviedo, Pamplona, Salamanca, Seville, Valencia
2021-02-08
Active, closed
Fundación GECP
Phase 3
210
Alicante, Badalona, Barcelona, L'Hospitalet de Llobregat, Bilbao, Cáceres, El Palmar, Girona
2021-01-13
Active, closed
Genmab
Phase 3
483
Badalona, Barcelona, Cadiz, Cáceres, Córdoba, Lleida, Madrid, Salamanca
2021-01-13
Active, closed
Bayer
Phase 3
402
Elche, Manacor, Palma de Mallorca, Sabadell, Alcorcón, Barcelona, Cáceres, Córdoba
2020-10-20
Active, closed
Hoffmann-La Roche
Phase 3
210
Bilbao, Badalona, Las Palmas de Gran Canaria, Barcelona, Cáceres, Madrid, Salamanca
2020-10-08
Active, closed
ADC Therapeutics S.A.
Phase 3
440
Barcelona, Cáceres, Madrid, Santander, Seville, Valencia
2020-09-16
Active, closed
Women's Cancer Study Group GmbH
Phase 3
1,260
Palma, Barcelona, Cáceres, Elche, Madrid, Manresa, Málaga, Pamplona
2020-09-02
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
239
L'Hospitalet de Llobregat, Cáceres, Pozuelo de Alarcón, Marbella, Pamplona, Barcelona, Madrid, Pozuelo de Alarcon (madrid)
2020-08-20
Recruiting
Taiho Oncology, Inc.
Phase 2/3
316
Badalona, L'Hospitalet de Llobregat, Pamplona, Oviedo, Barcelona, Cáceres, Girona, Granada
2020-05-21
Active, closed
GlaxoSmithKline
Phase 3
494
Barcelona, Cáceres, Gijón, L'Hospitalet de Llobrega, Murcia, PamplonaNavarra, Salamanca
2020-05-07
Active, closed
Merck Sharp & Dohme LLC
Phase 3
595
Badalona, Barcelona, Cáceres, Girona, Pozuelo de Alarcón, Valencia, Madrid, Seville
2019-07-24
Active, closed
Astellas Pharma Global Development, Inc.
Phase 2
393
Llobregat, Pamplona, Barcelona, Cáceres, Córdoba, Lleida, Madrid, Málaga
2019-03-15
Active, closed
PETHEMA Foundation
Phase 3
462
A Coruña, Albacete, Alicante, Badalona, Barcelona, Bilbao, Cáceres, Córdoba
2018-10-22
Active, closed
Hoffmann-La Roche
Phase 1/2
422
Barcelona, Cáceres, Madrid, Seville
2018-09-25
Active, closed
Fondazione Michelangelo
Phase 3
650
A Coruña, Alcoy, Alicante, Badajoz, Barcelona, Bilbao, Cáceres, Granada
2018-09-07
Active, closed
Janssen Research & Development, LLC
Phase 3
629
Badajoz, Badalona, Barcelona, Cáceres, Córdoba, Granada, Jaén, Las Palmas de Gran Canaria
2018-03-23
Active, closed
Fundación para la Formación e Investigación de los Profesionales de la Salud de Extremadura
Not applicable
152
Mérida, Plasencia, Cáceres
2018-03-14
Active, closed
AstraZeneca
Phase 2
273
Barcelona, Cáceres, Madrid, Palma de Mallorca, San Sebastián, Sant Cugat del Vallès, Seville, Valencia
2018-03-07
Active, closed
Hoffmann-La Roche
Phase 3
382
Palma de Mallorca, Córdoba, A Coruña, Las Palmas de Gran Canaria, Pamplona, Barcelona, Cáceres, Jaén
2017-09-20
Active, closed
Eli Lilly and Company
Phase 1
100
Ávila, Cáceres, Madrid
2016-11-14
Active, closed
Eisai Inc.
Phase 3
1,069
Santander, Barcelona, Cáceres, Córdoba, Madrid, Oviedo, Seville, Valencia
2016-10-13
Active, closed
Celgene
Phase 1/2
130
Barcelona, Cáceres, Madrid, Málaga, Valencia
2016-06-03
Active, closed
Alliance Foundation Trials, LLC.
Phase 3
5,796
A Coruña, Alicante, Badalona, Barcelona, Burgos, Castellon, Cáceres, Córdoba
2015-08
Active, closed
AstraZeneca
Phase 3
1,837
A Coruña, Ávila, Badajoz, Badalona, Barcelona, Castellon, Cáceres, Córdoba
2014-04-22
Recruiting
Jules Bordet Institute
Not applicable
1,000
A Coruña, Barcelona, Castellon, Cáceres, Lleida, Madrid, Seville, Valencia
2014-04
Active, closed
National Cancer Institute (NCI)
Phase 3
5,018
A Coruña, Albacete, Barcelona, Castellon, Cáceres, Donostia / San Sebastian, Girona, Madrid
2011-02-28
Active, closed
Genentech, Inc.
Phase 2
378
Elche, Jerez de la Frontera, Donostia / San Sebastian, Barcelona, Cáceres, Lleida, Madrid, Zaragoza
2008-10-16
